Why Alzamend Neuro Stock Soared Today
The company hopes to advance the standard of care for people with dementia.
Source: fool.com
Page 7 - Stephan Jackman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stephan Jackman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stephan Jackman Today - Breaking & Trending Today
FinancialNewsMedia.com: Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
PALM BEACH, Fla., Dec. 15, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs)
Source: finanznachrichten.de
Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs),...
Source: prnewswire.com
Alzamend Shares Rise After FDA Gives Positive Response to Pre-IND Filing for Immune-Boosting Alzheimers Vaccine
Shares of Alzamend Neuro Inc. traded 36% higher after the company reported that the U.S. FDA responded favorably to its Pre-IND application for AL002, a cell-based therapeutic vaccine designed to restore patients' immunological systems, providing them with the ability to combat Alzheimer's Disease. The FDA has granted the firm approval to initiate a combined Phase 1/2 clinical trial in Q1/22.
Source: streetwisereports.com